Diabetes Care Devices Market Size Analysis - Growth Trends & Forecasts (2025 - 2030)

The Diabetes Care Devices Market is segmented by Management Devices (Insulin Pumps, Insulin Syringes, Insulin Cartridges, Disposable Pens, and Jet Injectors), Monitoring Devices (Self-monitoring Blood Glucose and Continuous Glucose Monitoring), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America). The Industry Report Offers Values (USD Billion) for the Above Segments.

Diabetes Care Devices Market Size Analysis - Growth Trends & Forecasts (2025 - 2030)

Diabetes Care Devices Market Size

Diabetes Care Devices Market Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Market Size (2025) USD 65.74 Billion
Market Size (2030) USD 84.30 Billion
CAGR (2025 - 2030) 5.10 %
Fastest Growing Market North America
Largest Market North America

Major Players

Diabetes Care Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Diabetes Care Devices Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Diabetes Care Devices Market Analysis

The Diabetes Care Devices Market size is estimated at USD 65.74 billion in 2025, and is expected to reach USD 84.30 billion by 2030, at a CAGR of 5.1% during the forecast period (2025-2030). Key drivers fuelling the expansion of the diabetes devices market include increasing diabetes prevalence, heightened adoption of cost effective diabetes devices including insulin pens, glucose monitors, etc, and enhanced healthcare access for the general public. Further, type 1 diabetes arises from an immune system malfunction, whereas type 2 diabetes is associated with a sedentary lifestyle, leading to insulin resistance. Thus, type 1 diabetes is classified as insulin-requiring, while type 2 diabetes is termed insulin-dependent.

Global healthcare industry faces a significant challenge from the rising incidence of diabetes cases. For example, as per the International Diabetes Federation (IDF) 2024 update, 540 million people are living with diabetes across the globe. Looking ahead to 2045, projections from the IDF indicate a worrying trend; 1 in 8 adults, totaling around 783 million, will be diagnosed with diabetes, marking a 46% rise. Such escalating instances offer significant insights for diabetes care devices market analysis.


Digital health apps that not only display and summarize individual blood glucose measurements but also integrate relevant data like insulin doses, meals, and physical activity, are paving the way for enhanced self-management. These innovations alleviate the disease burden and elevate the standard of diabetes care. Moreover, the fusion of blood glucose monitoring with tools like insulin calculators, automated insulin titration software, and remote coaching offers crucial support to patients grappling with poorly controlled diabetes. For instance, as per the article published in January 2024 in the American Diabetes Association Journal, devices like the Omnipod 5, an automated insulin delivery (AID) system, are categorized under hybrid closed-loop (HCL) insulin delivery technologies. It comprises a tubeless pod insulin pump that wirelessly connects to a Dexcom G6 continuous glucose monitoring (CGM) sensor via Bluetooth. The system employs a control algorithm to adjust insulin delivery in real time based on glucose levels and is complemented by a mobile app featuring an integrated bolus calculator. Such advancements not only promise to uplift critical health outcomes but also bolster the market's prospects in the coming years.


Moreover, government initiatives and recommendations to undergo diabetes testing and continuous monitoring on time are set to boost market growth during the forecast period. For instance, every year on November 14, World Diabetes Day plays a pivotal role in amplifying global awareness about diabetes, a pressing public health issue affecting millions around the globe. In November 2024, the theme ‘Breaking Barriers, Bridging Gaps’ highlighted the urgent need for accessible, high-quality diabetes care, particularly for marginalized communities. The Government of India adopts a proactive, multi-faceted strategy to combat diabetes, focusing on improved healthcare access, awareness campaigns, and lifestyle promotion. Through these efforts, the government seeks to not only diminish the prevalence of diabetes but also mitigate its long-term complications, paving the way for a healthier future for all citizens, which ultimately drives the market growth over the forecast period.


In summary of this industry analysis, the rising prevalence of diabetes, coupled with an increasing demand for diabetes care devices, is driving the market's expansion. The high costs associated with advanced diabetic care devices could hinder the market's growth trajectory during the forecast period.

Diabetes Care Devices Industry Overview

The market is semi-consolidated and consists of global and local players. The competitive landscape includes an analysis of a few international as well as local companies that hold market shares. Key players in the diabetes care devices market research include Abbott Diabetes Care, Roche Diabetes Care, Dexcom, Medtronic, Novo Nordisk, LifeScan, Ascensia Diabetes Care, AgaMatrix, Bionime Corporation, Insulet Corporation, Medisana, Ypsomed, Trivida, Rossmax International Ltd., among others.


In terms of market share, few of the major players currently dominate the market. Market leaders and key players are at the forefront of developing CGM systems, test strips, and other diabetic care devices for diabetes. For example, in February 2024, DexCom Inc., a leading key player in real-time continuous glucose monitoring (CGM) for diabetics, introduced its latest CGM system, the Dexcom ONE+, across Spain, Belgium, Poland, and the Netherlands. Consequently, product launches are fueling segment growth by meeting crucial demands like enhanced accuracy, convenience, and user-friendliness in diabetes management. These launches underscore companies' commitment to innovation, aiming to boost patient outcomes and solidify their foothold in the competitive diabetes care device market. This move is poised to drive market growth during the forecast period.

Diabetes Care Devices Market Leaders

  1. Novo Nordisk

  2. Abbott

  3. Dexcom

  4. Medtronic

  5. Roche

  6. *Disclaimer: Major Players sorted in no particular order
Diabetes Care Devices Market Competitive Landscape
Need More Details on Market Players and Competiters?
Download PDF

Diabetes Care Devices Market News

  • November 2024: DexCom, Inc., a global frontrunner in glucose biosensing, teamed up with ŌURA, the creator of the premier smart ring, to forge a strategic alliance. This collaboration aims to empower millions and enhance their metabolic health. By merging Dexcom's glucose insights with ŌURA's data on vital signs, sleep patterns, stress levels, heart health, and physical activity, users of both platforms will gain a holistic view of their health.
  • September 2024: Abbott launched its inaugural over-the-counter glucose sensor in the United States, following closely on the heels of Dexcom's introduction of the competitive product. Dubbed Lingo, the device is designed for wellness monitoring, targeting individuals without diabetes. It's accessible to those aged 18 and above who aren't insulin users.
  • August 2024: DexCom, Inc., launched its over-the-counter glucose biosensor, Stelo, in the United States. The product delivers round-the-clock, tailored glucose insights straight to the smartphone, highlighting the impacts of food, exercise, and sleep on glucose levels.
  • March 2024: Roche announced encouraging topline results for its groundbreaking continuous glucose monitoring (CGM) solution in Italy. The system features a CGM sensor paired with two specialized apps, which display real-time glucose levels and provide predictive insights for the next 30 minutes and two hours.

Diabetes Care Devices Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
  • 4.3 Market Restraints
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value in USD Billion)

  • 5.1 Monitoring Devices
    • 5.1.1 Self-monitoring Blood Glucose
    • 5.1.1.1 Glucometer Devices
    • 5.1.1.2 Test Strips
    • 5.1.1.3 Lancets
    • 5.1.2 Continuous Glucose Monitoring
    • 5.1.2.1 Sensors
    • 5.1.2.2 Durables
  • 5.2 Management Devices
    • 5.2.1 Insulin Pumps
    • 5.2.1.1 Insulin Pump Device
    • 5.2.1.2 Insulin Pump Reservoir
    • 5.2.1.3 Infusion Set
    • 5.2.2 Insulin Syringes
    • 5.2.3 Insulin Cartridges
    • 5.2.4 Disposable Pens
    • 5.2.5 Jet Injectors
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Rest of North America
    • 5.3.2 Europe
    • 5.3.2.1 France
    • 5.3.2.2 Germany
    • 5.3.2.3 Italy
    • 5.3.2.4 Spain
    • 5.3.2.5 United Kingdom
    • 5.3.2.6 Russia
    • 5.3.2.7 Rest of Europe
    • 5.3.3 Latin America
    • 5.3.3.1 Mexico
    • 5.3.3.2 Brazil
    • 5.3.3.3 Rest of Latin America
    • 5.3.4 Asia-Pacific
    • 5.3.4.1 Japan
    • 5.3.4.2 South Korea
    • 5.3.4.3 China
    • 5.3.4.4 India
    • 5.3.4.5 Australia
    • 5.3.4.6 Vietnam
    • 5.3.4.7 Malaysia
    • 5.3.4.8 Indonesia
    • 5.3.4.9 Philippines
    • 5.3.4.10 Thailand
    • 5.3.4.11 Rest of Asia-Pacific
    • 5.3.5 Middle East and Africa
    • 5.3.5.1 Saudi Arabia
    • 5.3.5.2 Iran
    • 5.3.5.3 Egypt
    • 5.3.5.4 Oman
    • 5.3.5.5 South Africa
    • 5.3.5.6 Rest of Middle East and Africa

6. MARKET INDICATORS

  • 6.1 Type-1 Diabetes Population
  • 6.2 Type-2 Diabetes Population

7. COMPETITIVE LANDSCAPE

  • 7.1 COMPANY PROFILES
    • 7.1.1 Abbott Diabetes Care
    • 7.1.2 Roche Diabetes Care
    • 7.1.3 Dexcom
    • 7.1.4 Medtronic
    • 7.1.5 Novo Nordisk
    • 7.1.6 LifeScan
    • 7.1.7 Ascensia Diabetes Care
    • 7.1.8 AgaMatrix
    • 7.1.9 Bionime Corporation
    • 7.1.10 Insulet Corporation
    • 7.1.11 Medisana
    • 7.1.12 Ypsomed
    • 7.1.13 Trivida
    • 7.1.14 Rossmax International Ltd.
  • *List Not Exhaustive
  • 7.2 COMPANY SHARE ANALYSIS
    • 7.2.1 Self-monitoring Blood Glucose Devices
    • 7.2.1.1 Abbott Diabetes Care
    • 7.2.1.2 Roche Diabetes Care
    • 7.2.1.3 LifeScan
    • 7.2.2 Continuous Glucose Monitoring Devices
    • 7.2.2.1 Dexcom
    • 7.2.2.2 Medtronic
    • 7.2.2.3 Abbott Diabetes Care
    • 7.2.3 Insulin Devices
    • 7.2.3.1 Insulet Corporation
    • 7.2.3.2 Novo Nordisk

8. MARKET OPPORTUNITIES AND FUTURE TRENDS

Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Diabetes Care Devices Industry Segmentation

As per the scope of the report, Diabetes care devices are the hardware, equipment, and software used by diabetes patients to regulate blood glucose levels, prevent diabetes complications, lessen the burden of diabetes, and enhance the quality of life.


The diabetes care devices market is segmented into management devices and monitoring devices and geography. The management segment is further segmented into insulin pumps, insulin syringes, insulin cartridges, disposable pens, and jet injectors. The insulin pumps are further segmented into insulin pump device insulin pump reservoirs and infusion sets. The monitoring devices are further bifurcated into devices that self-monitor blood glucose and monitor continuous glucose. The self-monitoring blood glucose is further segmented into glucometer devices, test strips, and lancets. The continuous glucose monitoring segment is further segmented into sensors and durables The geography is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America. The report offers the value (in USD Billion) and volume (in Unit) for the above segments. Further, the report will cover a segment-wise breakdown (Value and Volume) for all the countries covered under the Table of Contents.

Monitoring Devices Self-monitoring Blood Glucose Glucometer Devices
Test Strips
Lancets
Continuous Glucose Monitoring Sensors
Durables
Management Devices Insulin Pumps Insulin Pump Device
Insulin Pump Reservoir
Infusion Set
Insulin Syringes
Insulin Cartridges
Disposable Pens
Jet Injectors
Geography North America United States
Canada
Rest of North America
Europe France
Germany
Italy
Spain
United Kingdom
Russia
Rest of Europe
Latin America Mexico
Brazil
Rest of Latin America
Asia-Pacific Japan
South Korea
China
India
Australia
Vietnam
Malaysia
Indonesia
Philippines
Thailand
Rest of Asia-Pacific
Middle East and Africa Saudi Arabia
Iran
Egypt
Oman
South Africa
Rest of Middle East and Africa
Need A Different Region or Segment?
Customize Now

Diabetes Care Devices Market Research FAQs

How big is the diabetes care devices market?

The diabetes care devices market size is estimated at USD 65.74 billion in 2025 and is expected to reach USD 84.30 billion by 2030, growing at a CAGR of 5.10% during the forecast period (2025-2030).

What is the future outlook for the diabetes devices market?

Closed-loop systems are evolving, integrating Continuous Glucose Monitors (CGMs) with insulin pumps. This advancement is refining automated insulin delivery, similar to an "artificial pancreas," which modulates insulin in response to real-time glucose fluctuations. Further, mobile health applications are set to experience rapid growth, enhancing patient engagement and self-management strategies in diabetic care.

How is technology, such as AI and IoT, impacting diabetes care devices?

Healthcare professionals are increasingly leveraging AI to enhance diabetes management, employing predictive analytics, fine-tuning insulin delivery, and tailoring patient care. With IoT-enabled devices, patients can monitor their glucose levels continuously and non-invasively, significantly boosting their comfort and commitment to treatment.

What are the challenges and opportunities in the diabetes care devices market?

The high costs of many advanced devices restrict their accessibility, particularly in developing regions. Technological advancements, including minimally invasive devices and digital health solutions, are underscoring significant opportunities in patient engagement and monitoring.

Who are the major players in the diabetes devices market?

The major players in the diabetes care devices market are Dexcom, Medtronic, Abbott, Novo Nordisk, Eli Lilly, etc., and other regional players.